Syngene reports revenue from operations up eight per cent in Q1
The first quarter results were against a strong quarter last year due to sales of COVID treatment, Remdesivir
Author
Covaxin demonstrates persistence of immunity and impact of third dose of inactivated COVID-19…
Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike…
EU secures over 50,000 additional doses of Bavarian Nordic’s monkeypox vaccine
The supply deal follows a first contract signed in June, when the EU ordered about 110,000 doses of Bavarian Nordic's vaccine
Bangladesh’s maiden homegrown COVID-19 vaccine gets clearance for human trials
The Bangavax vaccine, developed by local pharma company Globe Biotech, recently received clearance from the Directorate General of…
DCGI approves Themis Medicare’s Viralex as COVID-19 treatment
The drug is also effective for viruses causing viral respiratory infections
Poonawalla Fincorp ties-up with AIOCD for loan offerings to its members
Through this tie-up, Poonawalla Fincorp will extend business loans, loan against property, pre-owned cars and home loans to AIOCD…
UPS Healthcare announces next-generation in Premier product line
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and…
MedGenome offers clonoSEQ Assay in India
The clonoSEQ test may effectively detect and monitor Minimal Residual Disease (MRD) in patients with certain types of blood cancer
New data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular…
In the Tenaya and Lucerne studies, more than 60 per cent of Vabysmo patients could be treated every four months at two years. This…
Pfizer India partners with Max Super Speciality Hospitals
The aim of the partnership is to enhance scope of care and create avenues for new research